Prosus’s red report card for underperformers Byju’s, PharmEasy

This is the third time Prosus has marked down its valuation of the beleaguered edtech firm within a year.

30 November, 20231 min
0
Prosus’s red report card for underperformers Byju’s, PharmEasy

You may also like

Business
Story image

RBI wants IndusInd Bank promoters, the Hindujas, cut to size

After successive controversies and growing unease over promoter influence, the central bank is reshaping the lender—starting with management, moving to its board and tightening the screws on ownership.

Business
Story image

The weight-loss wave that’s changing India—one sector at a time

Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.

Business
Story image

Abu Dhabi’s $16 billion push to become a finance magnet

Highlights from Abu Dhabi Finance Week, Qatar’s new (and bolder) AI ambition and the bid for Warner Bros. Discovery.